Effect of finerenone on diabetic kidney disease outcomes with estimated glomerular filtration rate below 25 mL/min/1.73 m(2)

BACKGROUND: In the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease trial, finerenone reduced the risk of cardiovascular events in patients with chronic kidney disease (CKD) and type 2 diabetes, while in the Finerenone in Reducing Kidney Failure and Disease Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mima, Akira, Lee, Rina, Murakami, Ami, Gotoda, Hidemasa, Akai, Ryosuke, Kidooka, Sayumi, Nakamoto, Takahiro, Kido, Suguru, Lee, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366575/
https://www.ncbi.nlm.nih.gov/pubmed/37497038
http://dx.doi.org/10.1016/j.metop.2023.100251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366575/
https://www.ncbi.nlm.nih.gov/pubmed/37497038
http://dx.doi.org/10.1016/j.metop.2023.100251

Ejemplares similares